ghkcu epithalon GHK-CU – Peptide Foundry Epithalon (50mg) – Highland Park

Synthetic delta-sleep-inducing peptide improves sleep in insomniacs Schneider-Helmert D, Schoenenberger GA The Lancet (1981) This pioneering clinical study examined DSIP's effects in patients with chronic primary insomnia, representing one of the first controlled human trials of the peptide for sleep disorders

Our Approach Peptide therapy is one component of a broader regenerative and longevity toolkit

Chopp and Z

The cause of this condition seems to be disturbances in the recognition of pathogens microorganisms in the human intestine determined by alterations in the expression of pathogen recognition receptors, which include the already mentioned NOD2 (336, 340) and also TLRs and Rig-I like receptors

Protective effects of L-arginine on the intestinal epithelial barrier under heat stress conditions in rats and IEC-6 cell line

Ecto5nucleotidase (CD73) regulation by hypoxiainducible factor1 mediates permeability changes in intestinal epithelia